Indication
BCR-ABL1 Negative
2 clinical trials
18 products
7 drugs
Clinical trial
A Phase I/II Study of Azacitidine, Venetoclax and Pevonedistat in Adults With Newly Diagnosed Secondary or Therapy-Related AMLStatus: Active (not recruiting), Estimated PCD: 2025-01-31
Product
AzacitidineProduct
PevonedistatProduct
VenetoclaxClinical trial
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) Trial: PRIMEStatus: Terminated, Estimated PCD: 2020-12-10
Product
AbemaciclibProduct
AbirateroneProduct
AfatinibDrug
AtezolizumabProduct
BicalutamideProduct
BortezomibProduct
DabrafenibProduct
CabazitaxelProduct
DacomitinibProduct
CabozantinibProduct
DarolutamideDrug
UTD1Drug
AN0025Drug
CelecoxibProduct
DasatinibProduct
CobimetinibProduct
CopanlisibDrug
R-CHOPProduct
EnasidenibDrug
EntrectinibProduct
EnzalutamideDrug
Erlotinib